GB202108828D0 - Novel cancer therapy - Google Patents
Novel cancer therapyInfo
- Publication number
- GB202108828D0 GB202108828D0 GBGB2108828.1A GB202108828A GB202108828D0 GB 202108828 D0 GB202108828 D0 GB 202108828D0 GB 202108828 A GB202108828 A GB 202108828A GB 202108828 D0 GB202108828 D0 GB 202108828D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer therapy
- novel cancer
- novel
- therapy
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108828.1A GB202108828D0 (en) | 2021-06-18 | 2021-06-18 | Novel cancer therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108828.1A GB202108828D0 (en) | 2021-06-18 | 2021-06-18 | Novel cancer therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202108828D0 true GB202108828D0 (en) | 2021-08-04 |
Family
ID=77050550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2108828.1A Ceased GB202108828D0 (en) | 2021-06-18 | 2021-06-18 | Novel cancer therapy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202108828D0 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8788444B2 (en) | 2008-10-20 | 2014-07-22 | Nottingham Trent University | Data analysis method and system |
-
2021
- 2021-06-18 GB GBGB2108828.1A patent/GB202108828D0/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8788444B2 (en) | 2008-10-20 | 2014-07-22 | Nottingham Trent University | Data analysis method and system |
Non-Patent Citations (14)
Title |
---|
"Bioreversible Carriers in Drug Design", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS |
"Remington's Pharmaceutical Sciences", 1995, MACK PUBLISHING CO., pages: 1447 - 1676 |
"Synthetic Biology, Part A, Methods in Enzymology", vol. 498, 2011, article "Synthetic Biology, Part B, Computer Aided Design and DNA Assembly", pages: 2 - 500 |
B. ROEJ. CRABTREEA. KAHN: "DNA Isolation and Sequencing: Essential Techniques", 1996, JOHN WILEY & SONS |
D. M. J. LILLEYJ. E. DAHLBERG: "Methods of Enzymology: DNA Structure Part A: Synthesis and Physical Analysis of DNA Methods in Enzymology", 1992, ACADEMIC PRESS |
DAVID R. ENGELKEJOHN J. ROSSI: "Methods in Enzymology", vol. 392, 2005, article "RNA Interference", pages: 1 - 454 |
GAHROUDI ET AL., FEBS LETT., vol. 414, 1997, pages 521 - 526 |
GONG ET AL., PATHOL ONCOL RES., vol. 18, no. 4, October 2012 (2012-10-01), pages 989 - 96 |
HAMERS-CASTERMAN ET AL.: "Nature", vol. 363, 1993, pages: 446 - 448 |
HIGUCHISTELLA: "A.C.S. Symposium Series", vol. 14, 1987, article "Pro-drugs as Novel Delivery Systems" |
J. M. POLAKJAMES O'D. MCGEE: "Situ Hybridisation: Principles and Practice", 1984, OXFORD UNIVERSITY PRESS |
M.R. GREENJ. SAMBROOK: "Molecular Cloning: A Laboratory Manual", 2012, COLD SPRING HARBOR LABORATORY PRESS |
RAMOS-SEVILLANO ET AL., PLOS PATHOG, vol. 12, no. 3, 14 March 2016 (2016-03-14), pages e1005500 |
RIECHMANN, FEBS LETT, vol. 339, 1994, pages 285 - 290 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201905780D0 (en) | Cancer therapy | |
GB202301902D0 (en) | Combination therapy for cancer | |
GB202108303D0 (en) | Therapy | |
GB202108828D0 (en) | Novel cancer therapy | |
IL304436A (en) | Cancer therapy | |
GB202001963D0 (en) | Cancer therapy | |
GB202000984D0 (en) | Cancer therapy | |
GB202318158D0 (en) | Cancer therapy | |
GB202302018D0 (en) | Cancer therapy | |
GB202218395D0 (en) | Cancer therapy | |
GB202212918D0 (en) | Cancer therapy | |
IL300171A (en) | Combined therapy against cancer | |
GB202116680D0 (en) | Combination therapy for cancer | |
GB202103673D0 (en) | Combination therapy for cancer | |
GB201901368D0 (en) | Cancer therapy | |
GB202118025D0 (en) | Cancer treatment | |
GB202111930D0 (en) | Cancer treatment | |
GB202113791D0 (en) | Novel therapy | |
GB202107825D0 (en) | Novel therapy | |
GB202010314D0 (en) | Cancer treatment | |
GB202108827D0 (en) | Novel antibody cancer therapy | |
GB202001320D0 (en) | Novel Therapy | |
GB202208893D0 (en) | Combination therapy for cancer | |
GB202117706D0 (en) | Therapy | |
GB202303784D0 (en) | Cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |